万博体育 九州 365
News & Media
10/10/2018

J. MICHAEL BISHOP INSTITUTE OF CANCER RESEARCH HOLDS ITS FIRST ANNUAL DNA LEAF PRECISION ONCOLOGY SYMPOSIUM IN SUINING CITY, SICHUAN, CHINA

All roads led to the Suining city of Sichuan Province, China, on Oct. 10, 2018, as the J. Michael Bishop Institute of Cancer Research (MBICR) inaugurated its DNA Leaf Precision Oncology?Symposium. This annual symposium was specially organized to celebrate the
10/09/2018

SCIENTIFIC ADVISORY BOARD (SAB) OF J. MICHAEL BISHOP INSTITUTE OF CANCER RESEARCH HELD ITS FIRST MEETING IN CHENGDU

Chengdu, China, October 8-15, 2018?– The first meeting of the Scientific Advisory Board (SAB) of the J. Michael Bishop Institute of Cancer Research (MBICR) was?held between?October 8 and 15, 2018 in Chengdu, China. The board was?led?by Dr. J. Michael Bishop
10/09/2018

J. MICHAEL BISHOP INSTITUTE OF CANCER RESEARCH SIGNED A STRATEGIC COLLABORATION AGREEMENT WITH CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE ON OCTOBER 9, 2018

J. Michael Bishop Institute of Cancer Research (MBICR) Signed a Strategic Collaboration Agreement with Chengdu University of Traditional Chinese Medicine (CUTCM) on October 9, 2018. Therefore, the day marked a special day in the history of MBICR. The signing ceremony
10/09/2018

ROB JANOFF, THE ICONIC APPLE LOGO DESIGNER, DEBUTS THE DNA LEAF LOGO HE CRAFTED FOR THE J. MICHAEL BISHOP INSTITUTE OF CANCER RESEARCH IN CHENGDU

“MBICR Logo: 40 years after the bite of an apple, there is a therapeutic bite out of a leaf” October 9, 2018, is a memorable day in the history of the J. Michael Bishop Institute of Cancer Research (MBICR) as
05/25/2018

The Delegates of the J. Michael Bishop Institute of Cancer Research in Chengdu Visited the Francis Crick Institute in London on May 16, 2018

On May 16, 2018, Dr. Jing Zhang, co-director of MBICR, and professor Robert Lloyd FRS, member of the Scientific Advisory Board of MBICR, visited the Francis Crick Institute in London, a world-class biomedical research center. MBICR delegates were cordially welcomed
03/27/2018

The Royal Society Fellow Professor Robert Lloyd Visits MBICR, Giant Pandas, and Sanxingdui

The moment Professor Robert Lloyd landed at the Chengdu International Airport marked the first time that MBICR hosted a visit by its advisor from the United Kingdom. Dr. Jing Zhang, Co-Director of MBICR, and representatives of institute employees met with
03/27/2018

A Retrospect to the Year 2017: Seven Advantage Resources Attract J. Michael Bishop Institute of Cancer Research to Chengdu Tianfu International Bio-town

At the end of 2016, the preparatory committee members of the J. Michael Bishop Institute of Cancer Research (MBICR) uniformly cast their votes to settle up the institute in Chengdu Tianfu International Bio-town after overall investigation, comprehensive analysis and scientific
03/09/2018

Warmly Welcome Dr. Kevan M. Shokat to the SAB of the J. Michael Bishop Institute of Cancer Research

Dr. Kevan M. Shokat is the chair of the Department of Cellular and Molecular Pharmacology at the University of California at San Francisco and a Professor of Chemistry at the University of California at Berkeley. He is also an investigator
02/28/2018

2018 MBICR’s Institute-Wide Annual Safety Training

365体育会不会倒闭365bet体育在线手机版The MBICR Institutional Safety Committee (ISC) advocates the use of biosafety and chemical hygiene precautions that efficiently protect both laboratory workers and the environment from potentially hazardous agents in research. On February 28, 2018, the committee hosted an institute-wide annual
02/10/2018

Medical System Biologist Professor Frank Buchholz of EMBO Joins the Director’s Advisory Board of the J. Michael Bishop Institute of Cancer Research

? Dr. Frank Buchholz is a full professor at the University Hospital Carl Gustav Carus and its National Center for Tumor Diseases. He is also a principal investigator at German Cancer Research Center, the group leader at the Max Planck
02/10/2018

Stanford University Professor Dean Felsher MD-PhD Joins the Director’s Advisory Board of the J. Michael Bishop Institute of Cancer Research

? Dr. Dean Felsher is a medical oncologist affiliated with Stanford Health Care-Stanford Hospital, Professor of oncology and pathology, and director of oncology research at Stanford University. He has conducted world-class research in dissecting the molecular basis of initiation and
02/10/2018

Executive Vice President of Exelixis, Dr. Dana Aftab, Joins the Director’s Advisory Board of the J. Michael Bishop Institute of Cancer Research

? Dr. Dana Aftab, Ph.D. has been serving at Exelixis as Executive Vice President of Business Operations since February 2016, where he has completed almost 18 years. He began his tenure with Exelixis in the company’s drug discovery group, where
02/09/2018

PDX Pioneer Professor Alana Welm at the University of Oklahoma Joins the Director’s Advisory Board of the J. Michael Bishop Institute of Cancer Research

Alana Welm, Ph.D., is the Scott Zarrow Chair in Biomedical Research at the Oklahoma Medical Research Foundation and an investigator at Stephenson Cancer Center at the University of Oklahoma. Dr. Welm is a renowned scientist for pioneering work in the
12/30/2017

MBICR Attends the 4th?Community Sports and Games Festival

The 4th Community Sports and Games Festival took place on November 30, 2017 in the Tian Fu Life Tech Zone, and was jointly hosted by the local labor union and several community organizations to spread good-will and active involvement for
12/24/2017

2017 Christmas Barbecue Party

On December 24, 2017, MBICR hosted a barbecue party to celebrate Christmas at Hong Shi Park in Luhu Eco-City. All the members of the institute were warmly welcomed along with their families. The self-help barbecue was well organized by the
11/23/2017

Professor James H. Naismith Joins MBICR

Professor James H. Naismith is a Fellow of the Royal Society and Professor of Structural Biology at the University of Oxford. He also directs the Research Complex at Harwell (CRaH), which is a Research Council UK (RCK) project led by